Xbiotech, Inc.
Clinical trials sponsored by Xbiotech, Inc., explained in plain language.
-
New shot aims to tame painful arthritis flares
Disease control Not yet recruitingThis study is testing whether a new injectable drug called Natrunix, when added to standard methotrexate treatment, can better control the symptoms of moderate to severe rheumatoid arthritis. About 108 adults whose arthritis isn't well-controlled on methotrexate alone will receiv…
Phase: PHASE2 • Sponsor: XBiotech, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New antibody treatment trial targets chronic back pain disease
Disease control Not yet recruitingThis study is testing whether adding weekly Natrunix injections to standard care helps people with active axial spondyloarthritis, a type of inflammatory spinal arthritis. The trial will include 60 participants who are HLA-B27 positive and have active disease symptoms. Participan…
Phase: PHASE2 • Sponsor: XBiotech, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC